Cdk1/2 Inhibitor III (CAS 443798-55-8)

Cdk1/2 Inhibitor III is a synthetic molecule specifically designed to target and inhibit the activity of cyclin-dependent kinases 1 and 2 (Cdk1 and Cdk2), which are essential enzymes in the regulation of the cell cycle. These kinases play critical roles in controlling the progression of cells through various phases of the cell cycle, particularly the G1/S and the G2/M transitions. Cdk1/2 Inhibitor III works by interfering with the ATP-binding site of these enzymes, thereby preventing their catalytic activity and halting cell cycle progression. The inhibition of Cdk1 and Cdk2 disrupts the phosphorylation of key proteins required for cell cycle progression, leading to cell cycle arrest. This mechanism is especially relevant in the study of cellular proliferation and oncogenesis, where uncontrolled cell division is a hallmark. By selectively targeting these kinases, Cdk1/2 Inhibitor III serves as a powerful tool in cell biology and cancer research, allowing scientists to dissect the complex signaling networks that govern cell cycle regulation.